Astrazeneca Pharmaceuticals
May 18, 2012 at 11:55 | Source: Moneycontrol.com
May 16, 2012 at 12:24 | Source: Moneycontrol.com
May 15, 2012 at 15:50 | Source: Moneycontrol.com
Mar 29, 2012 at 15:36 | Source: Moneycontrol.com
Mar 28, 2012 at 13:15 | Source: Moneycontrol.com
News across the web »
Mar 18, 2012 at 12:05 | Source: The Hindu BusinessLine
Mar 06, 2012 at 23:02 | Source: The Hindu BusinessLine
Feb 02, 2012 at 20:12 | Source: Market Watch
Interact & exchange stock tips & market info »
Related News »
AstraZeneca PLC (AstraZeneca) is a leading pharmaceutical company. The company discovers, develops, produces and markets a broad range of biologics, prescription pharmaceuticals and vaccines for the treatment of diseases such as cancer, cardiovascular ...
May 20, 2012 at 16:31 | Source: Transworld News
Below are the three companies in the Pharmaceuticals industry with the highest dividend yields. Dividends can enhance returns for investors seeking income in addition to capital gains. AstraZeneca (NYSE:AZN) is highest with a dividend yield of 9.4%.
May 23, 2012 at 14:54 | Source: Financial News Network Online
Amylin Pharmaceuticals Inc. (AMLN) (AMLN) has lured suitors such as Pfizer Inc. (PFE) (PFE), AstraZeneca Plc (AZN) and Sanofi, which signed confidentiality agreements on the drugmaker’s sale process, said people familiar with the matter.
May 14, 2012 at 23:55 | Source: Businessweek
Amylin Pharmaceuticals, the US maker of diabetes-focused medicines, has attracted a string of potential suitors, including Anglo-Swedish group AstraZeneca, people close to the situation said. The move comes amid a flurry of M&A activity in the sector ...
May 15, 2012 at 18:17 | Source: Financial Times
Chressanthis, his research team and ZS consultants began to measure the behavior of primary care physicians and specialists in 2008 when Chressanthis was at AstraZeneca Pharmaceuticals LP. They drew from ZS' annual AccessMonitor™ report, which since 2006 ...
May 24, 2012 at 01:53 | Source: Science Daily
--(BUSINESS WIRE)--McCarter & English LLP is pleased to announce that Thomas A. Stevens, Assistant General Counsel, Global IP Litigation, at AstraZeneca Pharmaceuticals and formerly a senior deputy attorney general in Delaware’s Department of ...
May 22, 2012 at 19:06 | Source: Business Wire
May 15 (Bloomberg) -- Amylin Pharmaceuticals Inc. has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi, which signed confidentiality agreements on the drugmaker's sale process, said people familiar with the matter. Merck & Co ...
May 15, 2012 at 14:49 | Source: San Francisco Gate
Stevens, who was previously assistant general counsel, global IP litigation at AstraZeneca Plc (AZN)’s AstraZeneca Pharmaceuticals unit, will specialize in litigation related to pharmaceutical and biotech companies. He previously served as ...
May 24, 2012 at 04:02 | Source: Bloomberg
In Martin v. AstraZeneca Pharmaceuticals Plc, the plaintiffs made a broad range of allegations against three AstraZeneca companies in relation to the design, manufacture, marketing and sale of Seroquel®, a leading medicine used to treat schizophrenia and ...
May 21, 2012 at 13:09 | Source: Mondaq
Served as an advisor or consultant for: Alkermes, Inc.; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Eli Lilly and Company; DEY; Forest Laboratories, Inc.; Gerson Lehman Group; GlaxoSmithKline; Guidepoint Global; H.
May 23, 2012 at 22:04 | Source: Medscape News